Erasmus MC Alumni Network

The Erasmus MC Alumni Network is the best way to expand your knowledge and network, reminisce, or learn more about the current Erasmus MC.

Foundation

Registration Newsletter

Welcome to the Erasmus MC Alumni Network website

Stay up to date by visiting this website frequently. Would you like to receive our Erasmus MC Alumni newsletter, please sign up via our contact form.

Alumni in the spotlight

Student Talk

Welcome

Amazing Erasmus MC: News & stories about the people of Erasmus MC

More Amazing Erasmus MC

November 7, 2025
New mechanism in BRCA2 tumors discovered: why chemotherapy sometimes fails

Why do some BRCA2 tumors eventually stop responding to chemotherapy? Researchers at Erasmus MC discovered how these tumors are still able to repair their DNA damage and how they evade the effects of chemotherapy.
Read more
November 4, 2025
Nearly €20 Million to Drive Innovation in Imaging Technology

A national consortium led by Erasmus MC has been awarded €19.6 million through the NWO Large-Scale Research Infrastructures program. The consortium, known as AMICE (Advanced Multimodal Imaging Centers), will invest over the next decade in advancing and refining imaging technologies that are essential for cutting-edge biomedical research.
Read more
October 30, 2025
Screening reduces prostate cancer mortality, even after more than twenty years

A prostate cancer screening program can reduce prostate cancer mortality, even in the long term. That is the take-away from research conducted by Erasmus MC in a large European group of screened men. ‘The longer the follow-up, the more reliable the results.’
Read more
October 8, 2025
Biomarker may predict Parkinson’s disease progression

Researchers at Erasmus MC have discovered a biomarker in the blood that can predict the progression of Parkinson’s disease. ‘Knowing how severe the disease will be in three years allows doctors to plan treatment much more precisely. ’
Read more
July 28, 2025
New Erasmus MC Subsidiary Develops Personalized Immunotherapy

Erasmus MC has established a new company dedicated to developing a new form of immunotherapy. This new therapy — a personalized cancer vaccine — is intended for patients with pancreatic cancer.
Read more
July 23, 2025
New cause found for von Willebrand disease

Scientists at Erasmus MC have discovered that von Willebrand disease, the most common inherited bleeding disorder, is not always caused by a genetic defect in the von Willebrand factor gene. Defects in the mechanisms that control secretion of this hemostatic protein can also cause von Willebrand disease, they show.
Read more